| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 24/09/2024 | 15:30 | PR Newswire (US) | Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan | NASDAQ:CODX | Co Diagnostics Inc |
| 05/09/2024 | 15:30 | PR Newswire (US) | Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test | NASDAQ:CODX | Co Diagnostics Inc |
| 30/08/2024 | 22:30 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:CODX | Co Diagnostics Inc |
| 15/08/2024 | 15:30 | PR Newswire (US) | Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C. | NASDAQ:CODX | Co Diagnostics Inc |
| 08/08/2024 | 22:06 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:CODX | Co Diagnostics Inc |
| 08/08/2024 | 22:01 | PR Newswire (US) | Co-Diagnostics, Inc. Reports Second Quarter 2024 Financial Results | NASDAQ:CODX | Co Diagnostics Inc |
| 29/07/2024 | 15:30 | PR Newswire (US) | Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago | NASDAQ:CODX | Co Diagnostics Inc |
| 25/07/2024 | 15:30 | PR Newswire (US) | Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast | NASDAQ:CODX | Co Diagnostics Inc |
| 16/07/2024 | 22:15 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements | NASDAQ:CODX | Co Diagnostics Inc |
| 02/07/2024 | 15:30 | PR Newswire (US) | Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States | NASDAQ:CODX | Co Diagnostics Inc |
| 18/06/2024 | 19:30 | PR Newswire (US) | Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21 | NASDAQ:CODX | Co Diagnostics Inc |
| 14/06/2024 | 15:30 | PR Newswire (US) | Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform | NASDAQ:CODX | Co Diagnostics Inc |
| 28/05/2024 | 22:01 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:CODX | Co Diagnostics Inc |
| 09/05/2024 | 22:01 | PR Newswire (US) | Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results | NASDAQ:CODX | Co Diagnostics Inc |
| 25/04/2024 | 15:30 | PR Newswire (US) | Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast | NASDAQ:CODX | Co Diagnostics Inc |
| 24/04/2024 | 15:30 | PR Newswire (US) | Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan | NASDAQ:CODX | Co Diagnostics Inc |
| 12/04/2024 | 15:30 | PR Newswire (US) | Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event | NASDAQ:CODX | Co Diagnostics Inc |
| 04/04/2024 | 15:30 | PR Newswire (US) | Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions | NASDAQ:CODX | Co Diagnostics Inc |
| 21/03/2024 | 14:30 | PR Newswire (US) | Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote Address | NASDAQ:CODX | Co Diagnostics Inc |
| 18/03/2024 | 14:30 | PR Newswire (US) | Co-Diagnostics, Inc. CEO to Deliver Keynote Address at MarketsandMarkets 2024 in London, England | NASDAQ:CODX | Co Diagnostics Inc |
| 14/03/2024 | 21:01 | PR Newswire (US) | Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results | NASDAQ:CODX | Co Diagnostics Inc |
| 07/03/2024 | 15:30 | PR Newswire (US) | Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test | NASDAQ:CODX | Co Diagnostics Inc |
| 29/02/2024 | 15:30 | PR Newswire (US) | Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Webcast | NASDAQ:CODX | Co Diagnostics Inc |
| 01/02/2024 | 15:30 | PR Newswire (US) | Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for February 2024 | NASDAQ:CODX | Co Diagnostics Inc |
| 03/01/2024 | 15:30 | PR Newswire (US) | Co-Diagnostics, Inc. to Host Booth at CES 2024 January 9-12 | NASDAQ:CODX | Co Diagnostics Inc |
| 27/12/2023 | 15:30 | PR Newswire (US) | Co-Diagnostics, Inc. Completes Submission to FDA for Co-Dx PCR Pro | NASDAQ:CODX | Co Diagnostics Inc |
| 29/11/2023 | 15:30 | PR Newswire (US) | Co-Diagnostics, Inc. to Participate in the Piper Sandler 35th Annual Healthcare Conference in New York City on November 30, 2023 | NASDAQ:CODX | Co Diagnostics Inc |
| 09/11/2023 | 22:01 | PR Newswire (US) | Co-Diagnostics, Inc. Reports Third Quarter 2023 Financial Results | NASDAQ:CODX | Co Diagnostics Inc |
| 02/11/2023 | 14:30 | PR Newswire (US) | Co-Diagnostics, Inc. Announces Additional Grant Award for Tuberculosis Test in Development | NASDAQ:CODX | Co Diagnostics Inc |
| 31/10/2023 | 14:30 | PR Newswire (US) | Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for November 2023 | NASDAQ:CODX | Co Diagnostics Inc |